Results 241 to 250 of about 7,190,509 (398)
User Mode Choice Behavior in Public Transportation: A Systematic Literature Review
, 2022 Abigail Jee Qian Sua +5 more
openalex +1 more source
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Information Source Before Travelling and Choice of Traveling Mode
, 2019 Bilal Ahmad Ali Al-khateeb +1 more
openalex +2 more sources
Estimating the impact of parking on car ownership and commute mode choices
, 2021 Omid Khazaeian
openalex +2 more sources
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Molecular Oncology, EarlyView.Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source
Can an Experience with No Car Use Change Future Mode Choice Behavior? [PDF]
, 2019 Matúš Šucha +2 more
openalex +1 more source
The role of family firms’ generational heterogeneity in the entry mode choice in foreign markets
, 2020 S. Mariotti +2 more
semanticscholar +1 more source
Molecular Oncology, EarlyView.HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source